FIELD: medicine, hematology. SUBSTANCE: method involves the use of known beta-adrenoblocking agent of noncardioselective action - obsidan (other names - propranolol, anaprilin) as bone marrow hemopoiesis stimulating agent at condition of cytostatic myelodepression. EFFECT: enhanced effectiveness of agent.
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
AGENT STIMULATING ERYTHROIDAL AND GRANULOCYTIC HEMOPOIESIS STEMS IN CYTOSTATIC MYELODEPRESSION | 2003 |
|
RU2243782C1 |
HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
Authors
Dates
1996-06-10—Published
1992-12-18—Filed